-+ 0.00%
-+ 0.00%
-+ 0.00%

Applied DNA Sciences Positions TR8 PGx Testing Service As Pre-Emptive Testing For Safety Of Fluoropyrimidine-Based Cancer Therapeutics Following Publication Of FDA Safety Announcement

Benzinga·04/01/2025 13:48:56
Listen to the news

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases -